Waters Corporation (NYSE:WAT) Poised To Rebound Amid Integration-Driven Revenue Upside

Waters shows expanding top-line scale from recent acquisitions while near-term technical momentum shows signs of fatigue; fundamentals present mixed cash-flow strength against margin and valuation pressure. The immediate setup favors consolidation with a clear valuation premium as assessed by WMDST.

Recent News

July 27, 2026 — Waters launched the Xevo TQ Absolute XR IVD mass spectrometer, expanding its MassTrak IVD portfolio for clinical diagnostics. August 26, 2026 — Waters announced CEO participation in the Wells Fargo Healthcare Conference; management will present updated strategy and integration progress. September 11, 2026 — Waters scheduled a fireside chat at the J.P. Morgan U.S. All Stars Conference to discuss commercial traction and roadmap.

Technical Analysis

Directional indicators: ADX at 26.39 signals a strong trend environment. DI+ sits at 25.52 with a peak-and-reversal pattern (bearish), while DI- sits at 13.71 with a dip-and-reversal pattern (bearish). Together these indicators point to increasing downside pressure that could test short-term support relative to the current valuation.

MACD and momentum: MACD registers 5.52 with a peak-and-reversal profile (bearish momentum); the MACD currently sits marginally above its 5.24 signal line, suggesting momentum has weakened even as the short-term moving-average relationship remained briefly positive. That combination signals fading upward momentum and elevated risk of a pullback versus WMDST’s over-valued assessment.

MRO and RSI: MRO at 25.13 turned from a peak (price sits above the modeled target and has a higher probability of downwards mean reversion). RSI at 57.86 shows a peak-and-reversal pattern that confirms a loss of near-term bullish conviction despite not yet reaching classic overbought levels.

Price structure & breadth: Close at $420.57 trades above the 50-day average ($400.40) and the 200-day average ($361.86), indicating longer-term strength, but the 12-day EMA and 20-day average show a peak-and-reversal tone. Price sits near the upper Bollinger band (upper 1σ ~$423.26), increasing the likelihood of a short-term reversion to mid-range moving averages. Volume at 688,038 remains below the 10-day and 50/200-day averages, reducing conviction behind recent moves.

Support/resistance context: Ichimoku Tenkan/Kijun at $412.36 under current price and Senkou span support around $375–$387 provide layered support; a losing of the nearer supports would shift the near-term bias toward consolidation closer to the 50-day average. Overall, technicals favor consolidation with downside risk in the near term against a longer-term uptrend.

Fundamental Analysis

Revenue and growth: Total revenue $1,645,000,000 with YoY revenue growth of 80.08% and QoQ revenue change of -16.88%. The YoY increase reflects scale gains; quarterly dynamics show short-term variability that requires monitoring for sustainability.

Profitability and margins: Gross margin at 44.62% decreased YoY by 23.51%. Operating margin sits at -2.25% and EBIT margin at -4.92%; EBIT margin improved QoQ by 55.97% but contracted YoY by 119.78%. EBIT margin at -4.92% sits well below the industry peer mean (12.86%) and industry peer median (23.60%), though above the industry peer low. The negative EBIT margin indicates acquisition- and integration-related charges weighing on reported operating profitability even as sales scale expands.

Earnings and cash flow: Reported adjusted EPS $3.05 versus an estimate of $3.01 (EPS surprise +1.33%). Net income shows a loss of $136,000,000, while operating cash flow equals $311,000,000 and free cash flow $153,000,000, producing a free cash flow yield of 0.43% (below the industry peer mean of 0.68%). The company converted periodic earnings into positive operating cash flow, but free cash generation yields remain modest relative to market valuation.

Leverage and liquidity: Total debt $5,454,000,000 with net debt $4,547,000,000 and debt-to-equity 0.359 (35.9%), which sits below the industry peer mean of 0.453. Current ratio 1.86 and quick ratio 1.29 indicate acceptable near-term liquidity; cash and short-term investments total $539,000,000. Cash conversion cycle at ~198 days runs longer than the industry peer mean (~142 days), implying working capital ties that impact cash velocity.

Valuation multiples: Trailing P/E ~118.80 and forward P/E ~84.00; trailing P/E sits above the industry peer mean (~90.87) while price-to-book at 2.34 sits below the industry peer mean (~4.65). EV/revenue metrics show elevated enterprise multiples consistent with the stated valuation conclusion. WMDST values the stock as over-valued, reflecting a premium for scale and growth prospects that current margins and cash-flow yields do not yet fully support.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2026-06-30
REPORT DATE: 2026-08-04
NEXT REPORT DATE: 2026-11-03
CASH FLOW  Begin Period Cash Flow $ 462.0 M
 Operating Cash Flow $ 311.0 M
 Capital Expenditures $ -48.00 M
 Change In Working Capital $ -258.00 M
 Dividends Paid —
 Cash Flow Delta $ 77.0 M
 End Period Cash Flow $ 539.0 M
 
INCOME STATEMENT REVENUE
 Total Revenue $ 1.6 B
 Forward Revenue $ -1.23 B
COSTS
 Cost Of Revenue $ 911.0 M
 Depreciation $ 35.0 M
 Depreciation and Amortization $ 301.0 M
 Research and Development $ 122.0 M
 Total Operating Expenses $ 1.7 B
PROFITABILITY
 Gross Profit $ 734.0 M
 EBITDA $ 220.0 M
 EBIT $ -81.00 M
 Operating Income $ -37.00 M
 Interest Income $ 5.0 M
 Interest Expense $ 60.0 M
 Net Interest Income $ -55.00 M
 Income Before Tax $ -141.00 M
 Tax Provision $ -5.00 M
 Tax Rate 3.5 %
 Net Income $ -136.00 M
 Net Income From Continuing Operations $ -136.00 M
EARNINGS
 EPS Estimate $ 3.01
 EPS Actual $ 3.05
 EPS Difference $ 0.04
 EPS Surprise 1.329 %
 Forward EPS $ 4.14
 
BALANCE SHEET ASSETS
 Total Assets $ 24.8 B
 Intangible Assets $ 17.9 B
 Net Tangible Assets $ -2.75 B
 Total Current Assets $ 4.5 B
 Cash and Short-Term Investments $ 539.0 M
 Cash $ 539.0 M
 Net Receivables $ 2.0 B
 Inventory $ 1.4 B
 Long-Term Investments $ 489.0 M
LIABILITIES
 Accounts Payable $ 863.0 M
 Short-Term Debt $ 200.0 M
 Total Current Liabilities $ 2.4 B
 Net Debt $ 4.5 B
 Total Debt $ 5.5 B
 Total Liabilities $ 9.6 B
EQUITY
 Total Equity $ 15.2 B
 Retained Earnings $ 10.2 B
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share $ 154.70
 Shares Outstanding 98.225 M
 Revenue Per-Share $ 16.75
VALUATION
 Market Capitalization $ 35.6 B
 Enterprise Value $ 40.5 B
 Enterprise Multiple 184.121
Enterprise Multiple QoQ -16.115 %
Enterprise Multiple YoY 127.663 %
Enterprise Multiple IPRWA WAT: 184.121
high: 169.48
median: 69.492
mean: 21.148
low: -625.515
 EV/R 24.624
CAPITAL STRUCTURE
 Asset To Equity 1.629
 Asset To Liability 2.59
 Debt To Capital 0.264
 Debt To Assets 0.22
Debt To Assets QoQ -2.955 %
Debt To Assets YoY -32.42 %
Debt To Assets IPRWA high: 0.402
median: 0.257
mean: 0.238
WAT: 0.22
low: 0.045
 Debt To Equity 0.359
Debt To Equity QoQ -1.458 %
Debt To Equity YoY -49.608 %
Debt To Equity IPRWA high: 1.323
median: 0.471
mean: 0.453
WAT: 0.359
low: 0.052
PRICE-BASED VALUATION
 Price To Book (P/B) 2.342
Price To Book QoQ 13.54 %
Price To Book YoY -72.709 %
Price To Book IPRWA high: 11.257
median: 4.661
mean: 4.653
WAT: 2.342
low: 0.432
 Price To Earnings (P/E) 118.803
Price To Earnings QoQ -0.187 %
Price To Earnings YoY 6.298 %
Price To Earnings IPRWA high: 246.367
WAT: 118.803
mean: 90.868
median: 78.948
low: -284.104
 PE/G Ratio 9.165
 Price To Sales (P/S) 21.636
Price To Sales QoQ -13.105 %
Price To Sales YoY -9.972 %
Price To Sales IPRWA high: 42.389
mean: 22.522
WAT: 21.636
median: 18.091
low: 1.671
FORWARD MULTIPLES
Forward P/E 83.997
Forward PE/G 6.48
Forward P/S -28.968
EFFICIENCY OPERATIONAL
 Operating Leverage 3.436
ASSET & SALES
 Asset Turnover Ratio 0.067
Asset Turnover Ratio QoQ -22.0 %
Asset Turnover Ratio YoY -59.713 %
Asset Turnover Ratio IPRWA high: 0.176
median: 0.142
mean: 0.127
WAT: 0.067
low: 0.032
 Receivables Turnover 0.88
Receivables Turnover Ratio QoQ -10.371 %
Receivables Turnover Ratio YoY -17.695 %
Receivables Turnover Ratio IPRWA high: 2.199
mean: 1.422
median: 1.32
low: 1.216
WAT: 0.88
 Inventory Turnover 0.634
Inventory Turnover Ratio QoQ -3.409 %
Inventory Turnover Ratio YoY 3.812 %
Inventory Turnover Ratio IPRWA high: 1.815
mean: 0.887
median: 0.787
WAT: 0.634
low: 0.217
 Days Sales Outstanding (DSO) 103.731
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 198.341
Cash Conversion Cycle Days QoQ -24.956 %
Cash Conversion Cycle Days YoY -12.194 %
Cash Conversion Cycle Days IPRWA high: 414.712
WAT: 198.341
mean: 142.439
median: 124.919
low: 59.211
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 0.796
 CapEx To Revenue -0.029
 CapEx To Depreciation -1.371
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital $ 20.1 B
 Net Invested Capital $ 20.3 B
 Invested Capital $ 20.3 B
 Net Tangible Assets $ -2.75 B
 Net Working Capital $ 2.1 B
LIQUIDITY
 Cash Ratio 0.225
 Current Ratio 1.861
Current Ratio QoQ 4.096 %
Current Ratio YoY 6.121 %
Current Ratio IPRWA high: 12.256
mean: 3.399
median: 2.099
WAT: 1.861
low: 1.348
 Quick Ratio 1.287
Quick Ratio QoQ 13.934 %
Quick Ratio YoY 5.365 %
Quick Ratio IPRWA high: 11.468
mean: 2.739
median: 1.619
WAT: 1.287
low: 1.042
COVERAGE & LEVERAGE
 Debt To EBITDA 24.791
 Cost Of Debt 1.109 %
 Interest Coverage Ratio -1.35
Interest Coverage Ratio QoQ 62.001 %
Interest Coverage Ratio YoY -110.09 %
Interest Coverage Ratio IPRWA high: 34.293
median: 17.32
WAT: -1.35
mean: -2.617
low: -253.706
 Operating Cash Flow Ratio 0.13
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 98.44
DIVIDENDS
 Dividend Coverage Ratio —
 Dividend Payout Ratio —
 Dividend Rate —
 Dividend Yield —
PERFORMANCE GROWTH
 Asset Growth Rate 0.897 %
 Revenue Growth 29.834 %
Revenue Growth QoQ -16.876 %
Revenue Growth YoY 80.081 %
Revenue Growth IPRWA WAT: 29.834 %
high: 22.192 %
mean: 3.203 %
median: 2.058 %
low: -4.928 %
 Earnings Growth 12.963 %
Earnings Growth QoQ -132.089 %
Earnings Growth YoY -58.333 %
Earnings Growth IPRWA high: 46.602 %
WAT: 12.963 %
mean: 9.621 %
median: 9.559 %
low: -57.143 %
MARGINS
 Gross Margin 44.62 %
Gross Margin QoQ -3.855 %
Gross Margin YoY -23.506 %
Gross Margin IPRWA high: 76.963 %
mean: 55.06 %
median: 53.951 %
WAT: 44.62 %
low: 15.048 %
 EBIT Margin -4.924 %
EBIT Margin QoQ 55.971 %
EBIT Margin YoY -119.777 %
EBIT Margin IPRWA high: 26.564 %
median: 23.597 %
mean: 12.861 %
WAT: -4.924 %
low: -151.875 %
 Return On Sales (ROS) -2.249 %
Return On Sales QoQ -39.38 %
Return On Sales YoY -109.217 %
Return On Sales IPRWA high: 29.576 %
median: 21.744 %
mean: 13.19 %
WAT: -2.249 %
low: -152.992 %
CASH FLOW
 Free Cash Flow (FCF) $ 153.0 M
 Free Cash Flow Yield 0.43 %
Free Cash Flow Yield QoQ -423.308 %
Free Cash Flow Yield YoY 330.0 %
Free Cash Flow Yield IPRWA high: 1.932 %
mean: 0.676 %
median: 0.605 %
WAT: 0.43 %
low: -11.945 %
 Free Cash Growth -464.286 %
Free Cash Growth QoQ 247.923 %
Free Cash Growth YoY 404.286 %
Free Cash Growth IPRWA high: 14.857 %
median: 14.857 %
mean: 2.105 %
low: -83.352 %
WAT: -464.286 %
 Free Cash To Net Income -1.125
 Cash Flow Margin 18.906 %
 Cash Flow To Earnings -2.287
VALUE & RETURNS
 Economic Value Added $ 0.04
 Return On Assets (ROA) -0.552 %
Return On Assets QoQ 13.58 %
Return On Assets YoY -117.468 %
Return On Assets IPRWA high: 2.62 %
median: 2.126 %
mean: 0.957 %
WAT: -0.552 %
low: -21.393 %
 Return On Capital Employed (ROCE) -0.362 %
 Return On Equity (ROE) -0.009
Return On Equity QoQ 90.021 %
Return On Equity YoY -113.141 %
Return On Equity IPRWA high: 0.048
median: 0.031
mean: 0.018
WAT: -0.009
low: -0.235
 DuPont ROE -0.892 %
 Return On Invested Capital (ROIC) -0.385 %
Return On Invested Capital QoQ 142.138 %
Return On Invested Capital YoY -108.758 %
Return On Invested Capital IPRWA high: 3.434 %
median: 2.437 %
mean: 1.578 %
WAT: -0.385 %
low: -13.397 %

Six-Week Outlook

Expect short-term consolidation with a downside tilt as momentum indicators have peaked and MRO signals above-target price pressure. The balance of indicators suggests price may trade sideways to slightly lower while fundamentals digest integration-related costs and margin recovery paths. Monitor momentum re-acceleration (MACD trend stabilization and RSI re-acceleration) or a reduction in downside directional pressure (DI+ stabilization) for evidence the consolidation has completed; absent that confirmation, near-term action will likely remain range-bound with periodic tests of the 50-day average and Ichimoku support levels.

About Waters Corporation

Waters Corporation (NYSE:WAT) delivers analytical workflow solutions across Asia, the Americas, and Europe. The company operates through two primary segments: Waters and TA. Waters Corporation designs and manufactures high and ultra-performance liquid chromatography systems and mass spectrometry technology systems, along with support products such as chromatography columns and other consumables. Additionally, the company offers post-warranty service plans to ensure the longevity and efficiency of its products. In the TA segment, Waters Corporation develops and provides thermal analysis, rheometry, and calorimetry instruments. These tools play a crucial role in predicting the suitability and stability of various materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. The company also supplies software-based products that interface with its instruments and those of other manufacturers, enhancing the functionality and integration of its solutions. Waters Corporation serves a diverse clientele, including clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors. Its products support research and development, quality assurance, and a range of laboratory applications. Founded in 1958, Waters Corporation maintains its headquarters in Milford, Massachusetts.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.